PROFILE OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN PATIENTS WITH BLOOD DISORDERS

被引:0
|
作者
Zuk-Wasek, Anna [1 ]
Litwinska, Bogumila [1 ]
Traczyk, Zdzislawa [2 ]
机构
[1] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Virol, PL-00791 Warsaw, Poland
[2] Inst Haematol & Transfusiol, Dept Internal Dis, PL-02776 Warsaw, Poland
关键词
humans; Epstein-Barr virus; antibodies; blood disorders;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to investigate the profile of Epstein-Barr virus (EBV) antibodies and to compare this profile with the detectability of EBV DNA and compare this profile in healthy people with the profile in patients with blood disorders. The profile of antibodies was examined in serum from the following groups: 40 patients with blood disorders, but without EBV DNA in their lymphocytes, 44 patients with blood disorders and EBV DNA in lymphocytes, and 46 healthy people. EBV antibodies were detected by using ELISA commercial kits. The obtained results were analysed by Fisher's exact test. No significant differences in antibody profiles were found between EBV DNA-positive and EBV DNA-negative sera. Between patients and the control group, considerable differences were observed in reactivation and in past infection, and a significant difference was observed in chronic infection. These analyses suggest that EBV reactivation or chronic infection can be related with blood disorders and have an influence on the course of blood disorders.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 50 条
  • [31] MANIFESTATIONS OF EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS IN LIVER
    MARKIN, RS
    LIVER, 1994, 14 (01): : 1 - 13
  • [32] Resurrecting Epstein-Barr Virus
    Paganelli, Roberto
    PATHOGENS, 2022, 11 (07):
  • [33] Epstein-Barr virus.
    Bricaire, F
    ANNALES DE MEDECINE INTERNE, 1997, 148 (05): : 372 - 375
  • [34] Epstein-Barr Virus Gastritis
    Oki, Masayuki
    Ozawa, Hideki
    Takagi, Atsushi
    INTERNAL MEDICINE, 2017, 56 (06) : 743 - 744
  • [35] A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
    Zhong, Ling
    Krummenacher, Claude
    Zhang, Wanlin
    Hong, Junping
    Feng, Qisheng
    Zhao, Qinjian
    Chen, Yixin
    Zeng, Mu-Sheng
    Zeng, Yi-Xin
    Xu, Miao
    Zhang, Xiao
    VIROLOGY JOURNAL, 2022, 19 (01)
  • [36] Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients
    Deeba, Elie
    Koptides, Dana
    Gaglia, Efthychia
    Constantinou, Astero
    Lambrianides, Anastasia
    Pantzaris, Marios
    Krashias, Georges
    Christodoulou, Christina
    MOLECULAR IMMUNOLOGY, 2019, 105 : 270 - 275
  • [37] Potential in vitro activity of Kutapressin against Epstein-Barr Virus
    Rosenfeld, E
    Salimi, B
    OGorman, MRG
    Lawyer, C
    Katz, BZ
    IN VIVO, 1996, 10 (03): : 313 - 318
  • [38] Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state
    Sener, Asli Gamze
    Afsar, Ilhan
    Pinar, Ercan
    JOURNAL OF VIROLOGICAL METHODS, 2009, 159 (02) : 300 - 302
  • [39] Reactivation of Epstein-Barr virus in SFTSV infected patients
    Fang, Li-Zhu
    Dong, Yu-Hong
    Yan, Zhi-Jian
    Zhou, Chuan-Min
    Yu, Xue-Jie
    Qin, Xiang-Rong
    INFECTIOUS MEDICINE, 2023, 2 (03): : 195 - 201
  • [40] Epstein-Barr virus serology in patients with autoimmune thyroiditis
    Vrbikova, J
    Janatkova, I
    Zamrazil, V
    Tomiska, F
    Fucikova, T
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (01) : 89 - 92